Provided by Tiger Fintech (Singapore) Pte. Ltd.

Century Therapeutics, Inc.

0.5963
+0.03786.77%
Post-market: 0.5753-0.0210-3.52%19:31 EDT
Volume:472.58K
Turnover:280.44K
Market Cap:50.70M
PE:-0.33
High:0.6284
Open:0.5575
Low:0.5506
Close:0.5585
Loading ...

What Makes Century Therapeutics (IPSC) a New Buy Stock

Zacks
·
09 Nov 2024

Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults

TIPRANKS
·
07 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Century Therapeutics (IPSC), NeoGenomics (NEO)

TIPRANKS
·
06 Nov 2024

Century Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
06 Nov 2024

Century Therapeutics price target lowered to $5 from $9 at H.C. Wainwright

TIPRANKS
·
06 Nov 2024

Century Therapeutics Reports Q3 Results & Strategic Updates

TIPRANKS
·
06 Nov 2024

Century Therapeutics Shares Rise After Q3 Beats Estimates

MT Newswires Live
·
06 Nov 2024

Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
05 Nov 2024

Century Therapeutics reports Q3 EPS (37c), consensus (45c)

TIPRANKS
·
05 Nov 2024

BRIEF-Century Therapeutics Q3 Net Income USD -31.226 Million

Reuters
·
05 Nov 2024

Century Therapeutics: Estimates Its Cash, Cash Equivalents, & Investments Will Support Operations Into Second Half of 2026

THOMSON REUTERS
·
05 Nov 2024

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

THOMSON REUTERS
·
05 Nov 2024

Century Therapeutics Q3 Net Income USD -31.226 Million

THOMSON REUTERS
·
05 Nov 2024

Press Release: Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Dow Jones
·
05 Nov 2024

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
05 Nov 2024

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference

GlobeNewswire
·
04 Nov 2024